 |
Vaccinia Immune Globulin (Human) Intravenous |
|---|---|
| Trade Name | Cnj-016 |
| Orphan Indication | Complications of vaccinia vaccination |
| USA Market Approval | USA |
| USA Designation Date | 2004-06-18 00:00:00 |
| Sponsor | Cangene Corporation;104 Chancellor Matheson Road;Winnipeg, ManitobaR3T 5Y3 |
